The adaptive response is triggered by tumor-specific T cells via the production of IFN-γ and tumor-infiltrating lymphocytes (TILs), which can induce immune checkpoint molecules (such as CTLA-4) or immunosuppressive mediators (such as IDO1) to exert immunosuppressive effects. This evidence concerns the gene IFNG and neoplasm.